Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field

Journal of Law, Medicine and Ethics 40 (4):716-750 (2012)
  Copy   BIBTEX

Abstract

Nanomedicine is yielding new and improved treatments and diagnostics for a range of diseases and disorders. Nanomedicine applications incorporate materials and components with nanoscale dimensions where novel physiochemical properties emerge as a result of size-dependent phenomena and high surface-to-mass ratio. Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine products that enter the human body. These include drugs, biological products, implantable medical devices, and combination products that are designed to function in the body in ways unachievable at larger scales. Nanotherapeutics andin vivonanodiagnostics incorporate materials that are engineered at the nanoscale to express novel properties that are medicinally useful. These nanomedicine applications can also contain nanomaterials that are biologically active, producing interactions that depend on biological triggers. Examples include nanoscale formulations of insoluble drugs to improve bioavailability and pharmacokinetics, drugs encapsulated in hollow nanoparticles with the ability to target and cross cellular and tissue membranes and to release their payload at a specific time or location, imaging agents that demonstrate novel optical properties to aid in locating micrometastases, and antimicrobial and drug-eluting components or coatings of implantable medical devices such as stents.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,271

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
Revolution or Reform in Human Subjects Research Oversight.Steven Joffe - 2012 - Journal of Law, Medicine and Ethics 40 (4):922-929.
New Rules for Research with Human Participants?Jessica Berg & Nicole Deming - 2011 - Hastings Center Report 41 (6):10-11.

Analytics

Added to PP
2013-03-01

Downloads
88 (#187,764)

6 months
9 (#269,798)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

George Khushf
University of South Carolina
Ralph Hall
Virginia Tech
2 more

Citations of this work

Nanomedicine First-in-Human Research: Challenges for Informed Consent.Nancy M. P. King - 2012 - Journal of Law, Medicine and Ethics 40 (4):823-830.
Concepts of Risk in Nanomedicine Research.Linda F. Hogle - 2012 - Journal of Law, Medicine and Ethics 40 (4):809-822.
Concepts of Risk in Nanomedicine Research.Linda F. Hogle - 2012 - Journal of Law, Medicine and Ethics 40 (4):809-822.

View all 8 citations / Add more citations